ConductScience.org, home

Paper8892876

The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Wills MR and 6 others. J Virol, 1996. Cited by 572 papers, by iCite.

Cite this record

ConductScience Library. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. Papers, record 8892876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8892876

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
PubMed
Journal
J Virol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
572
iCite
Relative citation ratio, by iCite
12.7
iCite
Revised in PubMed
2020-12-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wills MRM R
2Carmichael AJA J
3Mynard KK
4Jin XX
5Weekes MPM P
6Plachter BB
7Sissons JGJ G

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, ViralMajor topic
CytomegalovirusMajor topic
Cytomegalovirus InfectionsMajor topic
Immediate-Early ProteinsMajor topic
PhosphoproteinsMajor topic
T-Lymphocytes, CytotoxicMajor topic
Viral Envelope ProteinsMajor topic
Viral Matrix ProteinsMajor topic
Viral ProteinsMajor topic
Amino Acid Sequence
Antibodies, Monoclonal
Antibodies, Viral
Antigen Presentation
Cell Line
HLA Antigens
HLA-A2 Antigen
Humans
Leukocytes, Mononuclear
Molecular Sequence Data
Receptors, Antigen, T-Cell, alpha-beta
Time Factors

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13029268Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes.J Exp Med1987https://conductscience.org/library/papers/3029268PubMed
27890324MHC ligands and peptide motifs: first listing.Immunogenetics1995https://conductscience.org/library/papers/7890324PubMed
32783585Measles virus-polypeptide specificity of the cytotoxic T-lymphocyte response in multiple sclerosis.J Neuroimmunol1989https://conductscience.org/library/papers/2783585PubMed
42138558Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.Eur J Immunol1990https://conductscience.org/library/papers/2138558PubMed
51693327Cellular and molecular basis of the protective immune response to cytomegalovirus infection.Curr Top Microbiol Immunol1990https://conductscience.org/library/papers/1693327PubMed
62172831A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin.Nature1990https://conductscience.org/library/papers/2172831PubMed
71700830Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.J Virol1990https://conductscience.org/library/papers/1700830PubMed
81707922Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression.J Immunol1991https://conductscience.org/library/papers/1707922PubMed
91714519Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.J Virol1991https://conductscience.org/library/papers/1714519PubMed
101652311Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.Blood1991https://conductscience.org/library/papers/1652311PubMed
111833769Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1833769PubMed
121372370Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.J Virol1992https://conductscience.org/library/papers/1372370PubMed
131328494Down-regulation of the class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus.J Gen Virol1992https://conductscience.org/library/papers/1328494PubMed
148093890
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
J Exp Med1993https://conductscience.org/library/papers/8093890PubMed
158384753Down-regulation of the surface expression of class I MHC antigens by human cytomegalovirus.Virology1993https://conductscience.org/library/papers/8384753PubMed
168388509Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus.J Virol1993https://conductscience.org/library/papers/8388509PubMed
178391985
Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses.
Eur J Immunol1993https://conductscience.org/library/papers/8391985PubMed
187691936Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.J Immunol1993https://conductscience.org/library/papers/7691936PubMed
198409412Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains.J Immunol1993https://conductscience.org/library/papers/8409412PubMed
208145043Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.J Exp Med1994https://conductscience.org/library/papers/8145043PubMed

See all 32 referencesDownload CSV of references

Cited by246

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 572 citations.

PMIDTitleJournalYearIn PapersSource
42694534Human leukocyte antigen genotype modulates cytomegalovirus- and Epstein-Barr virus-specific T-cell response in healthy donors for optimized virus-specific T-cell donor selection.Front Immunol2026https://conductscience.org/library/papers/42694534PubMed
42335212Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT.Blood Adv2026https://conductscience.org/library/papers/42335212PubMed
42118153PRECISE-seq reveals disease-relevant TCR repertoires with phenotypic plasticity.J Exp Med2026https://conductscience.org/library/papers/42118153PubMed
41871430Establishment of a Neonatal Natural Transmission Model for Cytomegalovirus Vaccine Development.J Infect Dis2026https://conductscience.org/library/papers/41871430PubMed
41122178Development of potent HLA-A02:01-restricted peptide-based cytotoxic T-cells against SARS-CoV-2 infections in patients awaiting a kidney transplant.Front Immunol2025https://conductscience.org/library/papers/41122178PubMed
40736257Cytomegalovirus latency-the sum of subtleties.J Virol2025https://conductscience.org/library/papers/40736257PubMed
40722038T cell receptor-like antibody specifically targets and eliminates cells infected with cytomegalovirus.J Transl Med2025https://conductscience.org/library/papers/40722038PubMed
39744948A vaccine against cytomegalovirus: how close are we?J Clin Invest2025https://conductscience.org/library/papers/39744948PubMed
39423238Virus-specific Th17 Cells Are Induced by Human Cytomegalovirus after Renal Transplantation.J Immunol2024https://conductscience.org/library/papers/39423238PubMed
39315550T cell responses and clinical symptoms among infants with congenital cytomegalovirus infection.JCI Insight2024https://conductscience.org/library/papers/39315550PubMed
39205483
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release.
MAbs2024https://conductscience.org/library/papers/39205483PubMed
38727277Immunomonitoring via ELISPOT Assay Reveals Attenuated T-Cell Immunity to CMV in Immunocompromised Liver-Transplant Patients.Cells2024https://conductscience.org/library/papers/38727277PubMed
38377192Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38377192PubMed
38020746Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?Transpl Int2023https://conductscience.org/library/papers/38020746PubMed
37972198Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.PLoS Pathog2023https://conductscience.org/library/papers/37972198PubMed
37430000Immune-checkpoint expression in antigen-presenting cells (APCs) of cytomegaloviruses infection after transplantation: as a diagnostic biomarker.Arch Microbiol2023https://conductscience.org/library/papers/37430000PubMed
37183817Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation.J Clin Invest2023https://conductscience.org/library/papers/37183817PubMed
37180637Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells.Oncoimmunology2023https://conductscience.org/library/papers/37180637PubMed
36979775Immortalized B Cells Transfected with mRNA of Antigen Fused to MITD (IBMAM): An Effective Tool for Antigen-Specific T-Cell Expansion and TCR Validation.Biomedicines2023https://conductscience.org/library/papers/36979775PubMed
36902866Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients.J Clin Med2023https://conductscience.org/library/papers/36902866PubMed

See all 246 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8892876

GET https://conductscience.org/api/papers/v1/8892876/references?page=2